↓ Skip to main content

Dove Medical Press

Cost-effectiveness of vedolizumab compared with conventional therapy for ulcerative colitis patients in the UK

Overview of attention for article published in ClinicoEconomics and Outcomes Research: CEOR, October 2017
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (53rd percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

policy
1 policy source

Readers on

mendeley
44 Mendeley
Title
Cost-effectiveness of vedolizumab compared with conventional therapy for ulcerative colitis patients in the UK
Published in
ClinicoEconomics and Outcomes Research: CEOR, October 2017
DOI 10.2147/ceor.s135609
Pubmed ID
Authors

Michele R Wilson, Ismail Azzabi Zouraq, Helene Chevrou-Severac, Ross Selby, Matthew C Kerrigan

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 44 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 44 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 9 20%
Other 7 16%
Researcher 5 11%
Student > Master 5 11%
Student > Postgraduate 3 7%
Other 6 14%
Unknown 9 20%
Readers by discipline Count As %
Medicine and Dentistry 17 39%
Pharmacology, Toxicology and Pharmaceutical Science 3 7%
Business, Management and Accounting 2 5%
Computer Science 1 2%
Immunology and Microbiology 1 2%
Other 8 18%
Unknown 12 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 September 2018.
All research outputs
#8,572,011
of 25,461,852 outputs
Outputs from ClinicoEconomics and Outcomes Research: CEOR
#202
of 525 outputs
Outputs of similar age
#128,164
of 331,480 outputs
Outputs of similar age from ClinicoEconomics and Outcomes Research: CEOR
#7
of 14 outputs
Altmetric has tracked 25,461,852 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 525 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.0. This one has gotten more attention than average, scoring higher than 52% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 331,480 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one is in the 42nd percentile – i.e., 42% of its contemporaries scored the same or lower than it.